posted on 2015-05-21, 09:36authored byAmar Joshi, Y Newbatt, P. C. McAndrew, M. Stubbs, R. Burke, Mark W. Richards, Chitra Bhatia, J. J. Caldwell, T. McHardy, I. Collins, Richard Bayliss
IRE1 transduces the unfolded protein response by splicing XBP1 through its C-terminal cytoplasmic kinase-RNase region. IRE1 autophosphorylation is coupled to RNase activity through formation of a back-to-back dimer, although the conservation of the underlying molecular mechanism is not clear from existing structures. We have crystallized human IRE1 in a back-to-back conformation only previously seen for the yeast homologue. In our structure the kinase domain appears primed for catalysis but the RNase domains are disengaged. Structure-function analysis reveals that IRE1 is autoinhibited through a Tyr-down mechanism related to that found in the unrelated Ser/Thr protein kinase Nek7. We have developed a compound that potently inhibits human IRE1 kinase activity while stimulating XBP1 splicing. A crystal structure of the inhibitor bound to IRE1 shows an increased ordering of the kinase activation loop. The structures of hIRE in apo and ligand-bound forms are consistent with a previously proposed model of IRE1 regulation in which formation of a back-to-back dimer coupled to adoption of a kinase-active conformation drive RNase activation. The structures provide opportunities for structure-guided design of IRE1 inhibitors
Funding
This work was
supported by Cancer Research UK grants (C24461/
A13231 and A12772 to R.B.) and (C309/A11566 to
Cancer Therapeutics Unit, ICR).
History
Citation
Oncotarget, 2015
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Biological Sciences/Department of Biochemistry
PMID: 25968568 [PubMed - as supplied by publisher]. Atomic coordinates and structure factors for apohIRE1
and compound 3-hIRE have been deposited in the PDB, accession codes 4Z7G and 4Z7H respectively.